RFK Jr. to require placebo-controlled studies for new vaccines

a year ago

RFK Jr. and the Trump administration plan to require placebo-controlled studies for new vaccines, potentially delaying COVID-19 vaccines and complicating approvals.
Vaccine experts criticize the move, arguing it undermines confidence in vaccines and could make them more expensive and less available.
The administration claims the requirement ensures vaccine safety, but experts dispute claims that key vaccines weren't tested against placebos.
The new standard could delay future COVID-19 vaccine updates, requiring large, expensive trials that may not be timely for seasonal needs.
Experts argue placebo trials for updated vaccines would be unethical and impractical, as existing vaccines are already proven safe and effective.
RFK Jr.'s stance is seen as dangerous by some, with concerns it could reduce vaccination rates and worsen disease outbreaks.

Hasty Briefsbeta